logo
Roche confirms guidance as H1 core operating profit up 6%

Roche confirms guidance as H1 core operating profit up 6%

Fashion Network6 days ago
Swiss drugmaker Roche reported a better-than-expected first-half operating profit on Thursday, which was up 6% due to strong sales growth from breast cancer drug Phesgo and allergy treatment Xolair.
Roche reported operating profit at 12 billion Swiss francs ($15.15 billion), above forecasts for around 11.7 billion, driven by higher sales and effective cost management, it said.
Roche added that the appreciation of the franc against the U.S. dollar had an adverse impact on results reported in francs compared with constant exchange rates. At currency-adjusted rates, profit was up 11%.
"We are confident in our continued strong momentum and resilience of our business due to our innovative on-market portfolio and pipeline," said CEO Thomas Schinecker.
He said Roche was still targeting an increase in full-year adjusted earnings per share at a high single-digit percentage.
Diagnostics division sales were stable at 7 billion francs, Roche said, citing growing demand for pathology solutions and blood screening tests as offsetting the effect of China's healthcare pricing reforms.
Headquartered in Basel, Switzerland, Roche owns skincare brand La Roche-Posay. The label's products include cleansers, moisturisers, and sunscreens.
© Thomson Reuters 2025 All rights reserved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Fragrance giant Symrise rethinks growth path for 2025
Fragrance giant Symrise rethinks growth path for 2025

Fashion Network

time5 hours ago

  • Fashion Network

Fragrance giant Symrise rethinks growth path for 2025

German fragrance and flavor manufacturer Symrise lowered its organic sales forecast for 2025 on Wednesday, citing more cautious consumer demand in key global markets. The Germany-based group, whose fragrances are used in perfumes by French luxury majors LVMH and Kering, now expects organic sales growth of 3% to 5% for the year, down from its previous forecast of 5% to 7%. It maintained its projected core profit (EBITDA) margin at around 21.5%, slightly above the original guidance of 21%. 'We are observing a shift in global market demand, with heightened consumer caution across certain sectors,' said Jean-Yves Parisot, chief executive officer of Symrise. He added that internal 'self-help initiatives' were expected to support margin improvements. The company aims to reach recurring cost savings of 40 million euros ($46.2 million) in 2025 through operational efficiency efforts, of which 20 million euros had already been achieved in the first half of the year, it said. Revenue for the January–June period fell 0.5% on a reported basis to 2.55 billion euros, below analyst expectations of 2.60 billion euros, according to a Vara Research poll. However, organic sales — which exclude currency exchange effects — rose 3.1% during the same period. Swiss competitor Givaudan also reported weaker-than-expected organic sales growth last week, highlighting broader concerns over softening demand in the sector. 'U.S. demand has simply weakened over the past few months,' said Olaf Klinger, chief financial officer at Symrise, during a conference call. He noted that the pet nutrition and UV filter categories were among the most affected. On the subject of U.S. tariffs, Klinger said the company had already implemented price increases in select cases and was prepared with additional mitigation strategies. 'We have the opportunity to relocate products if the tariff situation does not allow continued delivery from certain regions,' he said. 'We also have reformulation options, meaning sourcing raw materials from other regions to ultimately manage tariff situations.' ($1 = 0.8656 euros)

Fragrance giant Symrise rethinks growth path for 2025
Fragrance giant Symrise rethinks growth path for 2025

Fashion Network

time5 hours ago

  • Fashion Network

Fragrance giant Symrise rethinks growth path for 2025

The company aims to reach recurring cost savings of 40 million euros ($46.2 million) in 2025 through operational efficiency efforts, of which 20 million euros had already been achieved in the first half of the year, it said. Revenue for the January–June period fell 0.5% on a reported basis to 2.55 billion euros, below analyst expectations of 2.60 billion euros, according to a Vara Research poll. However, organic sales — which exclude currency exchange effects — rose 3.1% during the same period. Swiss competitor Givaudan also reported weaker-than-expected organic sales growth last week, highlighting broader concerns over softening demand in the sector. 'U.S. demand has simply weakened over the past few months,' said Olaf Klinger, chief financial officer at Symrise, during a conference call. He noted that the pet nutrition and UV filter categories were among the most affected. On the subject of U.S. tariffs, Klinger said the company had already implemented price increases in select cases and was prepared with additional mitigation strategies. 'We have the opportunity to relocate products if the tariff situation does not allow continued delivery from certain regions,' he said. 'We also have reformulation options, meaning sourcing raw materials from other regions to ultimately manage tariff situations.' ($1 = 0.8656 euros)

Fragrance giant Symrise rethinks growth path for 2025
Fragrance giant Symrise rethinks growth path for 2025

Fashion Network

time6 hours ago

  • Fashion Network

Fragrance giant Symrise rethinks growth path for 2025

German fragrance and flavor manufacturer Symrise lowered its organic sales forecast for 2025 on Wednesday, citing more cautious consumer demand in key global markets. The Germany-based group, whose fragrances are used in perfumes by French luxury majors LVMH and Kering, now expects organic sales growth of 3% to 5% for the year, down from its previous forecast of 5% to 7%. It maintained its projected core profit (EBITDA) margin at around 21.5%, slightly above the original guidance of 21%. 'We are observing a shift in global market demand, with heightened consumer caution across certain sectors,' said Jean-Yves Parisot, chief executive officer of Symrise. He added that internal 'self-help initiatives' were expected to support margin improvements. The company aims to reach recurring cost savings of 40 million euros ($46.2 million) in 2025 through operational efficiency efforts, of which 20 million euros had already been achieved in the first half of the year, it said. Revenue for the January–June period fell 0.5% on a reported basis to 2.55 billion euros, below analyst expectations of 2.60 billion euros, according to a Vara Research poll. However, organic sales — which exclude currency exchange effects — rose 3.1% during the same period. Swiss competitor Givaudan also reported weaker-than-expected organic sales growth last week, highlighting broader concerns over softening demand in the sector. 'U.S. demand has simply weakened over the past few months,' said Olaf Klinger, chief financial officer at Symrise, during a conference call. He noted that the pet nutrition and UV filter categories were among the most affected. On the subject of U.S. tariffs, Klinger said the company had already implemented price increases in select cases and was prepared with additional mitigation strategies. 'We have the opportunity to relocate products if the tariff situation does not allow continued delivery from certain regions,' he said. 'We also have reformulation options, meaning sourcing raw materials from other regions to ultimately manage tariff situations.' ($1 = 0.8656 euros)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store